Copyright: ©Author(s) 2026.
World J Virol. Mar 25, 2026; 15(1): 115210
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.115210
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.115210
Table 2 Clinical signs of Rift Valley fever
| Parameter | Mild form | Severe form |
| Onset | 2-6 days after infection | Usually develops after initial mild symptoms |
| Symptoms | Fever, muscle and joint pain, headache, vomiting, photophobia | Ocular disease, meningoencephalitis, haemorrhagic fever |
| Prevalence | Majority of infected individuals | Occurs in a small percentage (< 2%) of cases |
| Ocular involvement | Rare | Seen in 0.5%-2% of cases; may cause blurred vision or blindness |
| Neurological involvement | Absent | Occurs in < 1% of cases; symptoms include seizures, confusion, and coma |
| Bleeding disorders | Not observed | Occurs in < 1% of cases; may include internal bleeding and multi-organ failure |
| Duration | 4-7 days | Variable; prolonged and potentially life-threatening |
| Prognosis | Full recovery | May lead to permanent damage or death |
- Citation: Uppala PK, Karanam SK, Kandra NV, Edhi S. Rift Valley fever: An emerging zoonotic threat to global health and agriculture. World J Virol 2026; 15(1): 115210
- URL: https://www.wjgnet.com/2220-3249/full/v15/i1/115210.htm
- DOI: https://dx.doi.org/10.5501/wjv.v15.i1.115210